2018 issue 4

Volume 34, issue 4

Review article

Adverse effects of venlafaxine therapy and risk factors for their occurrence

Justyna Suwała¹, Marta Oleś¹, Anna Wiela-Hojeńska¹

1. Katedra i Zakład Farmakologii Klinicznej, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

Farmakoterapia w Psychiatrii i Neurologii 2018, 34 (4), 285–304
Date of publication: 08-01-2019
DOI: https://doi.org/10.33450/fpn.2019.01.003

Keywords: venlafaxine, adverse effects, risk factors

Abstract

Pharmacovigilance is an important aspect of depression treatment, considering that 40–90% of patients experience side effects of antidepressant use. This paper discusses the issues of optimising the use of venlafaxine, including its pharmacodynamic and pharmacokinetic properties, indications, adverse effects and risk factors for their occurrence, such as co-morbidities or genetic polymorphisms and interactions with other drugs.

Article in pdf format

Address for correspondence:
mgr farm. Justyna Suwała
Uniwersytet Medyczny
im. Piastów Śląskich we Wrocławiu
email: justyna.suwala@student.umed.wroc.pl